251 related articles for article (PubMed ID: 25596733)
1. SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination.
Lu W; Liu S; Li B; Xie Y; Adhiambo C; Yang Q; Ballard BR; Nakayama KI; Matusik RJ; Chen Z
Oncotarget; 2015 Jan; 6(2):771-88. PubMed ID: 25596733
[TBL] [Abstract][Full Text] [Related]
2. SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer.
Lu W; Liu S; Li B; Xie Y; Izban MG; Ballard BR; Sathyanarayana SA; Adunyah SE; Matusik RJ; Chen Z
Oncogene; 2017 Mar; 36(10):1364-1373. PubMed ID: 27869166
[TBL] [Abstract][Full Text] [Related]
3. KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis.
Li G; Kanagasabai T; Lu W; Zou MR; Zhang SM; Celada SI; Izban MG; Liu Q; Lu T; Ballard BR; Zhou X; Adunyah SE; Matusik RJ; Yan Q; Chen Z
Cancer Res; 2020 Nov; 80(21):4633-4643. PubMed ID: 32868382
[TBL] [Abstract][Full Text] [Related]
4. Jarid1b promotes epidermal differentiation by mediating the repression of Ship1 and activation of the AKT/Ovol1 pathway.
Sun X; Li Z; Niu Y; Zhao L; Huang Y; Li Q; Zhang S; Chen T; Fu T; Yang T; An X; Jiang Y; Zhang J
Cell Prolif; 2019 Sep; 52(5):e12638. PubMed ID: 31152465
[TBL] [Abstract][Full Text] [Related]
5. Co-targeting SKP2 and KDM5B inhibits prostate cancer progression by abrogating AKT signaling with induction of senescence and apoptosis.
Brown LK; Kanagasabai T; Li G; Celada SI; Rumph JT; Adunyah SE; Stewart LV; Chen Z
Prostate; 2024 Jun; 84(9):877-887. PubMed ID: 38605532
[TBL] [Abstract][Full Text] [Related]
6. JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level.
Huang D; Xiao F; Hao H; Hua F; Luo Z; Huang Z; Li Q; Chen S; Cheng X; Zhang X; Fang W; Hu X; Liu F
Cell Commun Signal; 2020 Oct; 18(1):169. PubMed ID: 33109187
[TBL] [Abstract][Full Text] [Related]
7. Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer.
Li B; Lu W; Yang Q; Yu X; Matusik RJ; Chen Z
Prostate; 2014 Apr; 74(4):421-32. PubMed ID: 24347472
[TBL] [Abstract][Full Text] [Related]
8. JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer.
Xiang Y; Zhu Z; Han G; Ye X; Xu B; Peng Z; Ma Y; Yu Y; Lin H; Chen AP; Chen CD
Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19226-31. PubMed ID: 18048344
[TBL] [Abstract][Full Text] [Related]
9. Histone Demethylase JARID1B Is Overexpressed in Osteosarcoma and Upregulates Cyclin D1 Expression via Demethylation of H3K27me3.
Wang W; Zheng K; Pei Y; Zhang X
Oncol Res; 2018 Apr; 26(3):373-384. PubMed ID: 28492139
[TBL] [Abstract][Full Text] [Related]
10. p27T187A knockin identifies Skp2/Cks1 pocket inhibitors for advanced prostate cancer.
Zhao H; Lu Z; Bauzon F; Fu H; Cui J; Locker J; Zhu L
Oncogene; 2017 Jan; 36(1):60-70. PubMed ID: 27181203
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor activation by polychlorinated biphenyls: epigenetic effects mediated by the histone demethylase Jarid1b.
Casati L; Sendra R; Poletti A; Negri-Cesi P; Celotti F
Epigenetics; 2013 Oct; 8(10):1061-8. PubMed ID: 23907094
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of JARID1B expression inhibits cell proliferation, induces apoptosis and blocks cell cycle in human acute lymphoblastic leukemia cells.
Huang YQ; Zou Y; Zheng RJ; Ma XD
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1366-1373. PubMed ID: 29565495
[TBL] [Abstract][Full Text] [Related]
13. Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma.
Fang L; Zhao J; Wang D; Zhu L; Wang J; Jiang K
Int J Mol Med; 2016 Jul; 38(1):172-82. PubMed ID: 27246838
[TBL] [Abstract][Full Text] [Related]
14. Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e.
Mitra D; Das PM; Huynh FC; Jones FE
J Biol Chem; 2011 Nov; 286(47):40531-5. PubMed ID: 21969366
[TBL] [Abstract][Full Text] [Related]
15. Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model.
Li X; Yokoyama NN; Zhang S; Ding L; Liu HM; Lilly MB; Mercola D; Zi X
Oncotarget; 2015 Dec; 6(39):41809-24. PubMed ID: 26497688
[TBL] [Abstract][Full Text] [Related]
16. Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor.
Kristensen LH; Nielsen AL; Helgstrand C; Lees M; Cloos P; Kastrup JS; Helin K; Olsen L; Gajhede M
FEBS J; 2012 Jun; 279(11):1905-14. PubMed ID: 22420752
[TBL] [Abstract][Full Text] [Related]
17. MiR-137 inhibits cell proliferation in acute lymphoblastic leukemia by targeting JARID1B.
Huang Y; Zou Y; Zheng R; Ma X
Eur J Haematol; 2019 Sep; 103(3):215-224. PubMed ID: 31206203
[TBL] [Abstract][Full Text] [Related]
18. The histone demethylase Jarid1b ensures faithful mouse development by protecting developmental genes from aberrant H3K4me3.
Albert M; Schmitz SU; Kooistra SM; Malatesta M; Morales Torres C; Rekling JC; Johansen JV; Abarrategui I; Helin K
PLoS Genet; 2013 Apr; 9(4):e1003461. PubMed ID: 23637629
[TBL] [Abstract][Full Text] [Related]
19. Jarid1b targets genes regulating development and is involved in neural differentiation.
Schmitz SU; Albert M; Malatesta M; Morey L; Johansen JV; Bak M; Tommerup N; Abarrategui I; Helin K
EMBO J; 2011 Nov; 30(22):4586-600. PubMed ID: 22020125
[TBL] [Abstract][Full Text] [Related]
20. Mutated SPOP E3 Ligase Promotes 17βHSD4 Protein Degradation to Drive Androgenesis and Prostate Cancer Progression.
Shi L; Yan Y; He Y; Yan B; Pan Y; Orme JJ; Zhang J; Xu W; Pang J; Huang H
Cancer Res; 2021 Jul; 81(13):3593-3606. PubMed ID: 33762355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
